4578 logo

Otsuka Holdings Co., Ltd. Stock Price

TSE:4578 Community·JP¥5.7t Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 8 Fair Values set on narratives written by author

4578 Share Price Performance

JP¥0
-7099.00 (-100.00%)
JP¥15,700.00
Fair Value
JP¥0
-7099.00 (-100.00%)
Price JP¥0

4578 Community Narratives

·
Fair Value JP¥15.7k 30.6% undervalued intrinsic discount

Digital Health And Aging Trends Will Open Markets Despite Risks

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value JP¥12.71k 14.3% undervalued intrinsic discount

Pharmaceutical Expansion Will Unlock Global Healthcare Opportunities Despite Risks

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value JP¥8k 36.2% overvalued intrinsic discount

Global Healthcare Cost Controls Will Crush Profitability

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
JP¥8k
36.2% overvalued intrinsic discount
Revenue
0.14% p.a.
Profit Margin
11.42%
Future PE
17.02x
Price in 2029
JP¥9.2k

Trending Discussion

Updated Narratives

4578 logo

4578: Share Buybacks And New Leukemia Filing Will Support Bullish Outlook

Fair Value: JP¥12.71k 14.3% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
4578 logo

4578: Future Repricing Will Rely On Share Buybacks Supporting Margins

Fair Value: JP¥15.7k 30.6% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
4578 logo

4578: Margin Optimism Around Recent Upgrade Will Ultimately Prove Overpriced

Fair Value: JP¥8k 36.2% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet, undervalued and pays a dividend.

0 Risks
4 Rewards

Otsuka Holdings Co., Ltd. Key Details

JP¥2.5t

Revenue

JP¥716.6b

Cost of Revenue

JP¥1.8t

Gross Profit

JP¥1.4t

Other Expenses

JP¥376.5b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Jul 31, 2026
715.07
71.52%
14.96%
3.0%
View Full Analysis

About 4578

Founded
1921
Employees
37758
CEO
Makoto Inoue
WebsiteView website
www.otsuka.com

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, it offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Chiyoda, Japan.

Recent 4578 News & Updates

Narrative Update Jun 15

4578: Share Buybacks And New Leukemia Filing Will Support Bullish Outlook

Analysts have nudged their price target on Otsuka Holdings higher to ¥12,708 from ¥12,083, citing updated assumptions around discount rates, profit margins, revenue growth and future P/E levels. What's in the News Otsuka Pharmaceutical submitted a supplemental application in Japan seeking approval to use Iclusig (ponatinib hydrochloride) as a first line treatment for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), along with a new 10 mg tablet formulation, source: company product announcement.
Narrative Update Jun 01

4578: Future Repricing Will Rely On Share Buybacks Supporting Margins

Analysts have adjusted the fair value price target for Otsuka Holdings from ¥15,445 to ¥15,700, reflecting updated assumptions around slightly higher revenue, profit margins and a modestly higher future P/E multiple. What's in the News A board meeting is scheduled for May 7, 2026, to consider a change in a specified subsidiary, which could affect how parts of the group are organized and reported (Key Developments).

Recent updates

No updates

Otsuka Holdings Co., Ltd. Competitors